A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study

NCT02158546 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

447

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: ALKS 5461
DRUG: Placebo

Sponsor

Alkermes, Inc.